Suppr超能文献

铥:钇铝石榴石激光前列腺汽化切除术治疗大容量前列腺。

Thulium:YAG vapoenucleation in large volume prostates.

机构信息

Department of Urology, Asklepios Hospital Barmbek, Hamburg, Germany.

出版信息

J Urol. 2011 Dec;186(6):2323-7. doi: 10.1016/j.juro.2011.07.073. Epub 2011 Oct 20.

Abstract

PURPOSE

Tm:YAG vapoenucleation was introduced as a minimally invasive treatment in patients with benign prostatic obstruction. The efficiency and safety of Tm:YAG vapoenucleation must still be confirmed in large volume prostates to prove the size independence of this promising treatment option. We evaluated the safety and efficiency of Tm:YAG vapoenucleation in patients with a prostate volume of 80 cc or greater and benign prostatic obstruction during a 12-month followup.

MATERIALS AND METHODS

Included in this trial were 90 consecutive patients undergoing 90 W Tm:YAG vapoenucleation. Vapoenucleation was done using the 2 μm continuous wave Tm:YAG laser combined with a mechanical tissue morcellator. We analyzed patient demographic, perioperative and 12-month followup data. Complications were assessed.

RESULTS

Mean preoperative prostate volume was 108.6 cc (range 80 to 200), mean International Prostate Symptom Score was 23.5 (range 8 to 35) and mean quality of life score was 4.3 (range 1 to 6). There was an 86% reduction (range 67% to 99%) in prostate volume on transrectal ultrasound by 12 months and an 88% decrease (range 58% to 100%) in prostate specific antigen. International Index of Erectile Function score remained stable. Peak urinary flow rate, International Prostate Symptom Score and quality of life improved significantly (p <0.001), as did post-void residual urine. The overall complication rate was manageable. Two patients required blood transfusion and 10 experienced early postoperative stress incontinence. During followup 7% of patients had symptomatic urinary tract infection and 2 had persistent grade I stress urinary incontinence. The reoperation rate due to urethral stricture was 1.8% during the 12-month followup.

CONCLUSIONS

Tm:YAG vapoenucleation is a safe, effective and size independent treatment option for benign prostatic obstruction. As shown by reductions in transrectal ultrasound prostate volume and prostate specific antigen, complete removal of the adenoma can be achieved by this procedure.

摘要

目的

钬激光前列腺剜除术作为一种微创治疗方法,已被引入治疗良性前列腺增生。钬激光前列腺剜除术的疗效和安全性仍需在大体积前列腺中得到证实,以证明这一有前途的治疗方法具有体积独立性。我们在 12 个月的随访中,评估了钬激光前列腺剜除术在前列腺体积为 80cc 或更大且患有良性前列腺增生的患者中的安全性和有效性。

材料和方法

本试验纳入 90 例连续行 90W 钬激光前列腺剜除术的患者。使用 2μm 连续波钬激光联合机械组织粉碎器进行前列腺剜除。我们分析了患者的人口统计学、围手术期和 12 个月随访数据。评估了并发症。

结果

平均术前前列腺体积为 108.6cc(范围 80 至 200),平均国际前列腺症状评分(IPSS)为 23.5(范围 8 至 35),平均生活质量评分(QoL)为 4.3(范围 1 至 6)。12 个月时,经直肠超声检查前列腺体积减少 86%(范围 67%至 99%),前列腺特异性抗原减少 88%(范围 58%至 100%)。国际勃起功能指数(IIEF)评分保持稳定。最大尿流率、IPSS 和生活质量显著改善(p<0.001),残余尿量减少。总的并发症发生率是可控的。2 例患者需要输血,10 例患者术后早期发生压力性尿失禁。随访期间,7%的患者发生有症状的尿路感染,2 例患者持续存在 I 级压力性尿失禁。12 个月随访期间,因尿道狭窄而再次手术的比例为 1.8%。

结论

钬激光前列腺剜除术是治疗良性前列腺增生的一种安全、有效且具有体积独立性的治疗方法。通过经直肠超声前列腺体积和前列腺特异性抗原的减少可以证明,该手术可以完全切除前列腺腺瘤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验